MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1201.97%
Quick Ratio
1201.97%
Cash Ratio
866.49%
Debt to Asset Ratio
29.36%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Right-of-use assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Lease liabilities, net of curren...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
676,114
753,102
893,369
573,610
Marketable securities
222,361
219,054
217,193
218,277
Prepaid expenses and other current assets
39,414
48,871
16,025
14,376
Total current assets
937,889
1,021,027
1,126,587
806,263
Property and equipmentat cost
34,287
32,850
32,750
32,173
Less accumulated depreciation and amortization
9,728
9,168
8,721
8,201
Property and equipment, net
24,559
23,682
24,029
23,972
Right-of-use assets
20,256
19,652
20,742
21,818
Restricted cash and other assets
11,309
15,589
15,600
15,006
Total assets
994,013
1,079,950
1,186,958
867,059
Accounts payable
12,153
10,781
8,082
12,061
Accrued expenses and other current liabilities
46,359
29,211
37,548
42,749
Vendor financing arrangement
14,151
6,224
-
-
Lease liabilities
5,366
5,033
4,995
5,039
Total current liabilities
78,029
51,249
50,625
59,849
Principal term loan balance
200,000
150,000
-
100,000
Unamortized debt discount and issuance costs
2,009
1,546
-
1,136
Accrued end of term fee
1,337
921
-
283
Long-term debt, net
199,328
149,375
148,921
99,147
Lease liabilities, net of current portion
14,505
14,271
15,283
16,280
Total liabilities
291,862
214,895
214,829
175,276
Common stock, 0.0001 par value 400,000,000 and 200,000,000 shares authorized at june 30, 2026 and december 31, 2025, respectively 165,670,880 and 164,950,540 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
16
16
16
14
Additional paid-in capital
2,398,040
2,382,172
2,367,780
1,975,460
Accumulated other comprehensive (loss) gain
-353
-137
475
496
Accumulated deficit
-1,695,552
-1,516,996
-1,396,142
-1,284,187
Total stockholders equity
702,151
865,055
972,129
691,783
Total liabilities and stockholders equity
994,013
1,079,950
1,186,958
867,059
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$676,114K (39.39%↑ Y/Y)Marketable securities$222,361K (11.80%↑ Y/Y)Prepaid expenses andother current assets$39,414K (181.03%↑ Y/Y)Property and equipmentatcost$34,287K (156.77%↑ Y/Y)Total current assets$937,889K (34.38%↑ Y/Y)Property and equipment,net$24,559K (332.76%↑ Y/Y)Right-of-use assets$20,256K (-11.39%↓ Y/Y)Restricted cash and otherassets$11,309K (350.92%↑ Y/Y)Less accumulateddepreciation and...$9,728K (26.70%↑ Y/Y)Total assets$994,013K (36.35%↑ Y/Y)Total liabilities andstockholders equity$994,013K (36.35%↑ Y/Y)Total stockholdersequity$702,151K (22.87%↑ Y/Y)Total liabilities$291,862K (85.25%↑ Y/Y)Accumulated deficit-$1,695,552K (-44.16%↓ Y/Y)Accumulated othercomprehensive (loss) gain-$353K (-240.08%↓ Y/Y)Additional paid-in capital$2,398,040K (37.24%↑ Y/Y)Long-term debt, net$199,328K (101.72%↑ Y/Y)Total currentliabilities$78,029K (88.15%↑ Y/Y)Lease liabilities,net of current...$14,505K (-15.97%↓ Y/Y)Common stock, 0.0001par value...$16K (45.45%↑ Y/Y)Unamortized debt discountand issuance costs$2,009K (67.98%↑ Y/Y)Principal term loanbalance$200,000K (100.00%↑ Y/Y)Accrued expenses andother current...$46,359K (106.46%↑ Y/Y)Vendor financingarrangement$14,151K Accounts payable$12,153K (-13.29%↓ Y/Y)Lease liabilities$5,366K (7.28%↑ Y/Y)Accrued end of term fee$1,337K (14755.56%↑ Y/Y)

Dyne Therapeutics, Inc. (DYN)

Dyne Therapeutics, Inc. (DYN)